REGULATORY INTELLIGENCE·Recall
American Health Packaging's Voriconazole Recall: cGMP Deviations in Repackaging Trigger Nationwide Class II Action
American Health Packaging initiated a Class II recall for Voriconazole Tablets 50 mg due to cGMP deviations in repackaging. This event, now terminated, highlights critical vulnerabilities in outsourced pharmaceutical handling. Procurement and regulatory teams must reinforce due diligence for repackaging partners to mitigate supply chain risks and ensure product integrity, impacting nationwide distribution.
90-Day Activity